Distinctive patterns of brain activity can predict cognitive decline and Alzheimer’s disease risk up to 12 years before symptoms appear, according to Stanford Medicine-led research that could enable earlier intervention.
The study, published in Science Advances, compared resting brain scans from two groups of adults aged 75 and older: those diagnosed with Alzheimer’s disease and “super agers” with memory capacity typical of people decades younger. From these contrasting patterns, researchers developed a scoring system called the Alzheimer’s Resilience-Vulnerability Connectome (ARC) score.
Using functional MRI data from 180 super agers and 110 people with Alzheimer’s disease, the team identified distinct patterns of underactivity and overactivity in various brain regions. The resulting ARC score distinguished super agers from those with Alzheimer’s with approximately 85% accuracy.
Researchers then applied this scoring system to more than 1,300 cognitively normal adults aged 55 to 70. Although no cognitive differences were apparent at the time of imaging, those with more Alzheimer’s-like scores exhibited faster cognitive decline over follow-up periods of up to 12 years. Those with super-ager-like scores showed the slowest declines.
The ARC score outperformed existing biomarkers, including amyloid-beta and tau measurements, in predicting conversion to Alzheimer’s disease. Combining the score with established biomarkers improved prediction further.
The findings suggest a potentially modifiable early biomarker for cognitive decline. The research team hopes that interventions such as transcranial magnetic stimulation or cognitive training might eventually shift brain patterns toward resilience, though this has not yet been tested. A trial investigating ARC scores before and after cognitive training is planned.
Source: Zhao K et al. A functional connectome identifies vulnerability to cognitive decline and Alzheimer’s disease progression. Science Advances (2026). DOI: 10.1126/sciadv.aed9351